E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 1/23/2008 in the Prospect News Bank Loan Daily.

Odyssey HealthCare outlines expected pricing on $150 million credit facility for VistaCare purchase

By Sara Rosenberg

New York, Jan. 23 - Odyssey HealthCare, Inc. detailed expected pricing on its proposed $150 million senior secured credit facility that will be used to help fund the acquisition of VistaCare, Inc., according to an SC 13D filed with the Securities and Exchange Commission Wednesday.

Both the $30 million five-year revolver and the $120 million six-year term loan are expected to be priced at Libor plus 300 basis points, with the revolver carrying a commitment fee of 25 bps.

Pricing on the revolver will be based on a leverage grid. If leverage is equal to or greater than 2.50:1.00, the spread will be Libor plus 325 bps; if leverage is equal to or greater than 1.75:1.00 but less than 2.50:1.00, the spread will be Libor plus 300 bps; if leverage is equal to or greater than 1.25:1.00 but less than 1.75:1.00, the spread will be Libor plus 275 bps; and if leverage is less than 1.25:1.00, the spread will be Libor plus 250 bps.

Financial covenants under the facility include a maximum leverage ratio and a minimum fixed-charge coverage ratio.

GE Capital is the lead arranger on the deal.

Odyssey is buying Scottsdale, Ariz.-based VistaCare, a provider of hospice services, for $8.60 per share, or $147.1 million.

The transaction is structured as a two-step process that includes a cash tender offer for all outstanding shares of VistaCare common stock followed by a cash merger, in which Odyssey would acquire any remaining outstanding shares of VistaCare common stock.

Completion of the acquisition is expected in the first quarter, subject to customary closing conditions, including the expiration or termination of any waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, and the tender of at least a majority of VistaCare's outstanding shares.

Odyssey is a Dallas-based provider of hospice care.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.